ITUS Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.6 |
Market Cap |
$74.57 M |
Shares Outstanding |
18.7 M |
Public Float |
16.26 M |
Address |
3150 Almaden Expressway San Jose California 95118 United States |
Employees | - |
Website | http://www.ituscorp.com |
Updated | 09/14/2018 |
ITUS Corp. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA. |